Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Neotrofin leteprinim (AIT-082): Completed Phase IIb trial enrollment

NeoTherapeutics Inc. (NEOT), Irvine, Calif.
Product: Neotrofin leteprinim (AIT-082)

Read the full 91 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE